Health TrialsbyHealthPanel

Testimonials and Navigation in Rheumatology

ConditionsRheumatologic DiseaseAutoimmune Diseases
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Alabama at Birmingham

About this trial

The overall goal of this study is to determine whether a novel, multi-modal, patient-directed behavioral intervention initiated in rheumatology clinics is an effective approach to improve uptake of updated COVID-19 vaccine.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults (18+ years) with known AIRD

Black race and/or Latinx ethnicity

Individuals who have not obtained the updated COVID-19 vaccine series (self-report)

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • Video comprised of AIRD patient narratives on COVID-19 vaccination thoughts and experiences

    Behavioral

    Participants will watch video focused on the importance of receipt of updated COVID-19 vaccination in patients with AIRD

  • Video on the importance of good oral health for patients with AIRD

    Behavioral

    Participants will watch video on the importance of good oral health in AIRD patients.

  • Brochure on COVID-19 vaccination in AIRD patients

    Behavioral

    Participants

  • Patient Navigation

    Behavioral

    Participants will receive phone calls from patient navigators to provide support and information for receipt of updated COVID-19 vaccination in patients with AIRD

  • Brochure on the importance of good oral health in AIRD patients

    Behavioral

    Participants will receive a brochure on the importance of good oral health in AIRD patients.

Treatment groups

1,170 Participants
are divided into 2 treatment groups
Group A: "Storytelling" video including patient narratives, brochure and patient navigationExperimental treatment 3 interventions
Group B: Attention Control: "Oral Health" video and "Oral Health" brochureActive comparator 2 interventions

Trial outcomes

Primary outcomes

1

Receipt of updated COVID-19 vaccination.

We will measure rates of receipt of updated COVID-19 vaccination.

Time frame
3 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Alabama at Birmingham

Lead sponsor

National Institute on Minority Health and Health Disparities (NIMHD)

Collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Collaborator

Source ClinicalTrials.gov
Apply now